Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.

Dilokthornsakul P, Chaiyakunapruk N, Nimpitakpong P, Jeanpeerapong N, Sruamsiri R.

Value Health. 2012 Jan-Feb;15(1 Suppl):S9-14. doi: 10.1016/j.jval.2011.11.019.

PMID:
22265074
[PubMed - indexed for MEDLINE]
2.

Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.

Sun SX, Ye X, Lee KY, Dupclay L Jr, Plauschinat C.

Clin Ther. 2008;30 Pt 2:2217-27. doi: 10.1016/j.clinthera.2008.12.005.

PMID:
19281916
[PubMed - indexed for MEDLINE]
3.

Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.

Cole JA, Norman H, Weatherby LB, Walker AM.

Pharmacotherapy. 2006 Aug;26(8):1157-64.

PMID:
16863491
[PubMed - indexed for MEDLINE]
4.

Health care and medication costs and use among older adults with heart failure.

Stroupe KT, Teal EY, Weiner M, Gradus-Pizlo I, Brater DC, Murray MD.

Am J Med. 2004 Apr 1;116(7):443-50.

PMID:
15047033
[PubMed - indexed for MEDLINE]
5.

Association between medication supplies and healthcare costs in older adults from an urban healthcare system.

Stroupe KT, Murray MD, Stump TE, Callahan CM.

J Am Geriatr Soc. 2000 Jul;48(7):760-8.

PMID:
10894314
[PubMed - indexed for MEDLINE]
6.
7.

Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.

Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS.

Am J Manag Care. 2009 Jul;15(7):437-45.

PMID:
19589011
[PubMed - indexed for MEDLINE]
Free Article
9.

Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA.

Am Heart J. 2004 Jul;148(1):122-8.

PMID:
15215801
[PubMed - indexed for MEDLINE]
10.

Association of refill adherence and health care use among adults with hypertension in an urban health care system.

Stroupe KT, Teal EY, Tu W, Weiner M, Murray MD.

Pharmacotherapy. 2006 Jun;26(6):779-89.

PMID:
16716131
[PubMed - indexed for MEDLINE]
11.

The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure.

Rattinger GB, Dutcher SK, Chhabra PT, Franey CS, Simoni-Wastila L, Gottlieb SS, Stuart B, Zuckerman IH.

Am J Geriatr Pharmacother. 2012 Feb;10(1):69-80. doi: 10.1016/j.amjopharm.2011.11.003. Epub 2012 Jan 20.

PMID:
22264854
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Medication adherence and Medicare expenditure among beneficiaries with heart failure.

Lopert R, Shoemaker JS, Davidoff A, Shaffer T, Abdulhalim AM, Lloyd J, Stuart B.

Am J Manag Care. 2012 Sep;18(9):556-63.

PMID:
23009306
[PubMed - indexed for MEDLINE]
Free Article
13.

Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.

Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL.

Ann Pharmacother. 2005 Nov;39(11):1785-91. Epub 2005 Oct 11.

PMID:
16219900
[PubMed - indexed for MEDLINE]
14.

Economic implications of treatment guidelines for congestive heart failure.

Shibata MC, Nilsson C, Hervas-Malo M, Jacobs P, Tsuyuki RT.

Can J Cardiol. 2005 Dec;21(14):1301-6.

PMID:
16341301
[PubMed - indexed for MEDLINE]
15.

Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.

Baser O, Andrews LM, Wang L, Xie L.

J Med Econ. 2011;14(5):576-83. doi: 10.3111/13696998.2011.596873. Epub 2011 Jul 6.

PMID:
21728914
[PubMed - indexed for MEDLINE]
16.

Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.

Pittman DG, Chen W, Bowlin SJ, Foody JM.

Am J Cardiol. 2011 Jun 1;107(11):1662-6. doi: 10.1016/j.amjcard.2011.01.052. Epub 2011 Mar 23.

PMID:
21439533
[PubMed - indexed for MEDLINE]
17.

Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.

Watz R, Ekstrand AB, Engelbrektson V, Beermann B.

Eur J Clin Pharmacol. 2005 May;61(3):209-14. Epub 2005 Mar 11.

PMID:
15761755
[PubMed - indexed for MEDLINE]
18.

A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.

Zhang Y, Fonarow GC, Sanders PW, Farahmand F, Allman RM, Aban IB, Love TE, Levesque R, Kilgore ML, Ahmed A.

Am J Cardiol. 2011 Nov 15;108(10):1443-8. doi: 10.1016/j.amjcard.2011.06.066. Epub 2011 Sep 3.

PMID:
21890091
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fraction.

Komukai K, Yagi H, Ogawa T, Date T, Morimoto S, Kawai M, Hongo K, Taniguchi I, Yoshimura M.

Circ J. 2008 Dec;72(12):2004-8. Epub 2008 Oct 29.

PMID:
18957786
[PubMed - indexed for MEDLINE]
Free Article
20.

The economic burden of congestive heart failure in a managed care population.

Xuan J, Duong PT, Russo PA, Lacey MJ, Wong B.

Am J Manag Care. 2000 Jun;6(6):693-700.

PMID:
10977478
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk